Gazette Tracker
Gazette Tracker

Core Purpose

This corrigendum revises the ceiling price of Synchrobreathe Inhaler, as previously notified under S.O. 5496(E) dated 19.12.2024.

Detailed Summary

This official corrigendum, issued by the National Pharmaceutical Pricing Authority, revises a previously issued notification S.O. 5496(E) dated 19.12.2024 concerning the ceiling price of Synchrobreathe Inhaler Device produced by Cipla Ltd. Specifically, it corrects the separate ceiling price for the formulation 'Synchrobreathe Inhaler for Budesonide Inhalation (MDI) 200 mcg/dose for 200 doses in one inhaler'. The price is adjusted upwards from Rs. 41.20 to Rs. 81.20. All other terms and conditions outlined in the original notification S.O. 5496(E) remain unchanged and in effect.

Full Text

REGD. No. D. L.-33004/99 The Gazette of India CG-DL-E-07022025-260824 EXTRAORDINARY PART II-Section 3-Sub-section (ii) PUBLISHED BY AUTHORITY No. 658] NEW DELHI, FRIDAY, FEBRUARY 7, 2025/MAGHA 18, 1946 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) CORRIGENDUM New Delhi, the 7th February, 2025 S.O. 662(E).— In the National Pharmaceutical Pricing Authority's notification S.O. 5496(E) dated 19.12.2024 in relation to the fixation separate price of Synchrobreathe Inhaler Device for M/s Cipla Ltd under Para 11(3), published in the Gazette of India, Extraordinary, the Entry at Sl. No. 2 of the Table, both in Hindi & English version, be read as follows: Instead of +-----+------------------------------------------------------+------------+--------------------------------------------------------------------+ | S. | Formulation | Unit | Separate Ceiling Price of Synchrobreathe | | No. | | | Inhaler in respect of formulations in column | | | | | (2) (in Rs.) | +=====+======================================================+============+====================================================================+ | (1) | (2) | (3) | (4) | +-----+------------------------------------------------------+------------+--------------------------------------------------------------------+ | 2 | Synchrobreathe Inhaler for Budesonide | 1 inhaler | 41.20 | | | Inhalation (MDI) 200 mcg/dose for 200 | | | | | doses in one inhaler | | | +-----+------------------------------------------------------+------------+--------------------------------------------------------------------+ Read as +-----+------------------------------------------------------+------------+--------------------------------------------------------------------+ | S. | Formulation | Unit | Separate Ceiling Price of Synchrobreathe | | No. | | | Inhaler in respect of formulations in column | | | | | (2) (in Rs.) | +=====+======================================================+============+====================================================================+ | (1) | (2) | (3) | (4) | +-----+------------------------------------------------------+------------+--------------------------------------------------------------------+ | 2 | Synchrobreathe Inhaler for | 1 inhaler | 81.20 | | | Budesonide Inhalation (MDI) 200 | | | | | mcg/dose for 200 doses in one inhaler | | | +-----+------------------------------------------------------+------------+--------------------------------------------------------------------+ All the notes and other contents mentioned in the original order S.O. 5496(E) dated 19.12.2024 shall remain the same [PN/261/129/2025/F/F. No. 8(129)/2025/D.P./NPPA-Div.-II] MAHAVEER SAINI, Dy. Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Never miss important gazettes

Create a free account to save gazettes, add notes, and get email alerts for keywords you care about.

Sign Up Free